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Abstract
Background: Completed genome projects have revealed an astonishing diversity of transposable genetic
elements, implying the existence of novel element families yet to be discovered from diverse life forms.
Concurrently, several better understood transposon systems have been exploited as efficient tools in molecular
biology and genomics applications. Characterization of new mobile elements and improvement of the existing
transposition technology platforms warrant easy-to-use assays for the quantitative analysis of DNA transposition.
Results: Here we developed a universal in vivo platform for the analysis of transposition frequency with class II
mobile elements, i.e., DNA transposons. For each particular transposon system, cloning of the transposon ends and
the cognate transposase gene, in three consecutive steps, generates a multifunctional plasmid, which drives
inducible expression of the transposase gene and includes a mobilisable lacZ-containing reporter transposon. The
assay scores transposition events as blue microcolonies, papillae, growing within otherwise whitish Escherichia coli
colonies on indicator plates. We developed the assay using phage Mu transposition as a test model and validated
the platform using various MuA transposase mutants. For further validation and to illustrate universality, we
introduced IS903 transposition system components into the assay. The developed assay is adjustable to a desired
level of initial transposition via the control of a plasmid-borne E. coli arabinose promoter. In practice, the
transposition frequency is modulated by varying the concentration of arabinose or glucose in the growth medium.
We show that variable levels of transpositional activity can be analysed, thus enabling straightforward screens for
hyper- or hypoactive transposase mutants, regardless of the original wild-type activity level.
Conclusions: The established universal papillation assay platform should be widely applicable to a variety of
mobile elements. It can be used for mechanistic studies to dissect transposition and provides a means to screen or
scrutinise transposase mutants and genes encoding host factors. In succession, improved versions of transposition
systems should yield better tools for molecular biology and offer versatile genome modification vehicles for many
types of studies, including gene therapy and stem cell research.
Background
Transposable DNA elements constitute a class of dis-
crete genome segments capable of moving from one
genomic location to another [1]. These common gen-
ome residents are present in all kingdoms of life, being
particularly abundant in eukaryotes [1,2], where they
cover a sizeable fraction of the genome space (e.g.,
~45% in human [3] and nearly 85% in maize [4]). Com-
pleted genome sequences demonstrate a wide diversity
among mobile DNA and imply the existence of novel
transposable element families yet to be discovered from
a multitude of diverse life forms [2]. Mobile DNA ele-
ments produce genetic variation, supply material for
genome innovations (e.g., new genes) and provoke gen-
ome instability [5], evidently earning them a highly sig-
nificant role in the course of evolution.
Transposable elements can be exploited in many types
of advanced genetic studies. Typical applications include
insertional mutagenesis [6], genome manipulation [7],
transgenesis [8], functional genomics studies [9,10], gene
therapy [11,12] and generation of induced pluripotent
stem cells [12]. Such methodologies are currently under
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any medium, provided the original work is properly cited.strong development, and it is expected that novel trans-
position-based applications and new strategies will
emerge in the near future.
Transposable elements which move via a DNA inter-
mediate (i.e., class II elements or DNA transposons [1])
are widespread, both in prokaryotes and in eukaryotes.
For transposition, they share a common overall reaction
mechanism, albeit with some variation in details among
different element families [13]. Characteristically, DNA
transposons are mobilised by a machinery typically
encoded by the elements themselves, and the most criti-
cal component is the catalytic protein, a transposase.
Initiating transposition, the transposase binds sequence-
specifically the transposon ends and, by synapsing the
ends as a multimer, assembles a protein-DNA complex
called a transpososome. Within the transpososome,
transposase catalyses two chemical reactions, donor
DNA cleavage and DNA strand transfer, ultimately
attaching the transposon DNA to the target DNA.
Because of the unity in their reaction mechanisms [13],
similar research approaches and analytical methods can
be used to study both prokaryotic and eukaryotic DNA
transposons.
Bacteriophage Mu uses DNA transposition for propa-
gation and encodes one of the most thoroughly charac-
terised transposition machineries [14]. Despite the
complexity of Mu transposition in natural contexts (e.g.,
certain auxiliary factors involved; see Discussion), a sub-
stantially simpler reaction can be performed in vitro.
This minimal component reaction requires only a sim-
ple reaction buffer and three purified macromolecular
components: MuA transposase, mini-Mu transposon
DNA and target DNA [15]. The minimal system yields
transposition products highly efficiently and with low
target site selectivity [15,16]. In general, these properties
make the Mu reaction ideal for a variety of advanced
molecular biology [15,17-19], protein engineering
[20-22] and genomics [9,23] applications. With an addi-
tion of an in vivo step, the minimal system can also be
used for efficient gene delivery in bacteria, yeast and
mammalian cells [24-26].
Various methods have been developed in the past for
the in vivo analysis of transposition frequency, with typi-
cal examples including mating-out and phage assays
[27,28], but these methods are not ideal for large-scale
studies. Currently, the most widely used methods to
study transposition in vivo exploit coloured microcolo-
nies (papillae), growing within otherwise colourless bac-
terial colonies. Initially, such papillation assays were
designed to score events involving transposon excision
f r o mas p e c i f i cg e n el o c u s[ 2 9 ] .M o r er e c e n t l y ,m o s t
papillation assays have exploited a reporter transposon,
typically including lacZ as a marker gene. Insertion of
the reporter transposon into a genomic locus under the
control of an active promoter would generate a gene
fusion, facilitating the expression of the lacZ gene,
detectable as coloured Lac
+ papillae on colourless Lac
-
colonies. The number of papillae per colony is propor-
tional to the frequency of transposition events catalysed
by the transposase. Useable papillation assays are cur-
rently available for a number of transposons, and typical
examples include the assays for Tn5 [30], Tn7 [31],
Tn10 [32], IS903 [33] and Mu [34]. All present-day
papillation assays are characteristically element-specific,
many of them lack adjustability and some are compli-
cated by the use of several plasmids. Clearly, there exists
a need for further methodology development, and a
papillation assay that could eliminate the above limita-
tions would be beneficial.
An increasing number of transposon systems have
recently been adapted for advanced molecular biology
and genomics applications, and their modification for
better performance is under development. Concurrently,
owing to genome projects, new transposons are being
discovered essentially on a daily basis. Both improve-
ment of the existing transposition applications and char-
acterization of new transposition systems require robust
quantitative assays. In this report, we describe a general
in vivo platform for the quantitative analysis of transpo-
sition that should be applicable to a variety of mobile
DNA elements.
Results
Au n i v e r s a lin vivo assay that could be used for the
quantitative analysis of mobile DNA activity in various
transposition systems would be a valuable tool for future
transposon studies and application development. With
this goal, we set up a platform that is based on the
transformation of E. coli with a single plasmid driving
transposon mobilization (Figure 1). The plasmid is engi-
neered to enable straightforward construction of a
reporter transposon for any specific DNA transposon
system, and it contains a controllable unit for the indu-
cible expression of the cognate transposase protein. The
platform provides a visual read-out with blue microcolo-
nies (papillae) growing within otherwise whitish bacter-
ial colonies and allows the adjustment of the
transposition frequency to a quantifiable range. As a test
system for the platform development, we utilized bacter-
iophage Mu transposition. For further assessment of the
assay and for the demonstration of its universality, we
additionally employed IS903 transposition.
Papillation assay
Initially, we constructed the papillation assay plasmid
pLHH4 (Figure 1a), which encodes the phage Mu trans-
posase and, in addition, contains a mobilisable mini-Mu
reporter transposon. This pBR322-derived plasmid
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as a standard selectable marker. The plasmid also
includes the arabinose/glucose-controllable PBAD pro-
moter of E. coli, driving the inducible expression of
MuA transposase. The expression unit is bordered by
strong transcription terminators to prevent surplus gene
expression from sequences flanking the unit. The mini-
Mu transposon (Δ1-8LacZ-Cat-Mu) contains, as an
inverted repeat, a 50-bp segment of Mu R-end DNA in
each of the transposon ends. As a reporter gene, the
transposon contains a promoterless, 5’-terminally trun-
cated E. coli lacZ gene (Δ1-8lacZ), lacking the codons for
amino acids 1-8. The transposon also includes the cat
gene for chloramphenicol selection.
The papillation assay for Mu transposition takes
advantage of the introduction of the plasmid pLHH4
into a phenotypically Lac
- E. coli strain, and the plasmid
facilitates the reporter transposon mobilisation upon
sufficient transposase expression. Successful transposi-
tion into an expressed chromosomal gene in the appro-
priate orientation and reading frame gives rise to lacZ
gene fusions. These events can be detected as blue
papillae on a colony grown on an indicator plate con-
taining X-gal, with each papilla representing an indepen-
dent transposition event (Figure 1b).
Colony phenotypes and papillation characteristics of
different E. coli strains
We evaluated three E. coli strains: DH10B, DH5a and
JM109 (Additional file 1) with regard to their suitability
for the papillation assay. These standard laboratory
strains are phenotypically Lac
-, and they grow as whitish
colonies on X-gal indicator plates. As a low-papillation-
frequency control, we also included strain HT321 in the
evaluation. This strain harbours a mutation in the pcnB
locus, resulting in a reduced plasmid copy number [35],
and has previously been used to identify host mutations
that increase transposition frequency in IS903,T n 10
and Tn552 systems [33]. Plasmid pLHH4 was trans-
formed into the cells, and colonies were grown for a
115-h reference time period on a standard papillation
medium with varying arabinose concentrations (Table
1). The critical characteristics evaluated were: (1) colony
size, because large colonies would potentiate a broad
dynamic range for the assay; (2) the number of papillae
generated should be adjustable by arabinose over a wide
range of concentrations; (3) a reasonable maximum
transposition frequency should be attained; (4) clearly
defined papillae should be evenly distributed on indivi-
dual colonies; and (5) the number of the papillae per
colony should not be overly influenced by the number
of growing bacterial colonies on a given plate.
Strain DH10B formed large colonies with a convex cen-
ter and generated a relatively high maximum number of
Figure 1 Adjustable in vivo papillation assay. (a) Papillation assay
plasmid pLHH4. This plasmid contains the MuA transposase-
encoding gene under the arabinose-inducible E. coli PBAD promoter,
and the mobilisable mini-Mu reporter transposon Δ1-8LacZ-Cat-Mu.
(b) Generation of papillae. The papillation assay plasmid is
transferred into a phenotypically Lac
- E. coli strain. Expression of the
transposase protein is induced by arabinose, mobilising the reporter
transposon. Transposition of the element into an expressed gene
(geneX) in the correct orientation and reading frame will form a
geneX::Δ1-8lacZ gene fusion, and a b-galactosidase fusion protein will
be expressed. Such transposition events can be detected on
indicator plates after prolonged incubation as blue microcolonies on
otherwise whitish colonies. The level of transposition can be
adjusted by varying the transposase expression via changes in
arabinose or glucose concentration.
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the increase in the arabinose concentration, but not lin-
early, and two maxima were observed (at 0.001 and 1%
arabinose concentrations; data not shown). The reason
f o rt h i ss o m e w h a tu n e x p e c t e db e h a v i o u ri sn o tk n o w n
but might possibly point to unknown alterations in the
arabinose transporter systems (see Discussion). Most
papillae were distributed in the center of the colony,
and the number of papillae on even-sized colonies was
somewhat influenced by the number of growing colonies
per plate (Additional file 2).
Strain DH5a formed large flat colonies, and the num-
ber of papillae correlated well with the arabinose con-
centration in the growth medium. A high maximum
number of clearly defined papillae formed throughout a
colony. The number of growing colonies per plate did
not overly influence the frequency of transposition. Par-
ticularly within the range of 40 to 200 colonies per
plate, papillae formed with a very similar rate (Addi-
tional file 2).
Strain JM109 generated medium-size, irregularly
shaped colonies. The number of papillae on a colony
was proportional to the arabinose concentration used,
reaching the level of ~40 papillae per colony upon
115-h incubation. Up to ~120 papillae per colony
formed with a prolonged (164 h) incubation time (data
not shown). Clearly defined papillae formed throughout
a colony, but curiously, ~7% of the colonies appeared
completely white, thus exhibiting Lac
- phenotype; the
same clones were also proline auxotrophs (data not
shown). These data point to the loss of the resident
F’-episome, which in this strain encodes the critical lac-
tose utilization and proline biosynthesis proteins.
The control strain HT321 generated large colonies
and with the 115-h reference incubation time exhibited
a low transposition frequency (up to ~10 papillae per
colony), too low to unambiguously evaluate arabinose
responsiveness. However, with prolonged incubation
time (164 h), up to ~30 papillae per colony could be
observed, and arabinose dependency was apparent (data
not shown).
The effect of temperature on transposition frequency
Strain DH5a appeared ideal for the further characteriza-
tion of the papillation assay. We next examined the
effect of growth temperature on papillation. DH5a cells
carrying the plasmid pLHH4 were grown on papillation
plates in standard growth conditions (0.1% arabinose) at
four different temperatures: 22°C (room temperature),
25°C, 30°C and 37°C. Emerging papillae were enumer-
ated as a function of incubation time (Figure 2). At each
temperature, visible papillae began to appear on colonies
after a prolonged incubation period, and the growth rate
of the bacteria apparently dictated the time course of
the appearance. The two lower temperatures produced a
modest number of papillae with a plateau in their
appearance. In contrast, the two higher temperatures
generated papillae in increasing numbers. Yielding a
measure for the maximum dynamic range of the assay,
we were able to enumerate papillae up to a time point
where ~700 discernible blue spots per colony were visi-
ble; thereafter the papillae fused, and the entire colony
turned blue. At 30°C and 37°C, papillae formation
appeared linear between the time points ~100-150 h
and ~50-80 h, respectively. For further studies, we chose
to use incubation at 30°C, as at this temperature papillae
accumulated more slowly, allowing a more convenient
and accurate papillae enumeration.
MuA expression and transposition frequency
The expression level of MuA transposase should influ-
ence the transposition frequency measurable by the
papillation assay. We therefore studied the MuA expres-
sion level and transposition frequency under variable
inducer concentrations. The former was studied using
liquid cultures and the latter, in a separate experiment,
using papillation analysis on plate cultures.
The initial MuA expression analysis was done with
whole-cell lysates of liquid cultures grown under vari-
able arabinose concentrations. SDS-PAGE and Western
blotting were used to reveal population-average protein
expression levels of MuA (Figure 3a). The data indicated
that MuA expression was increased by the increase in
the arabinose concentration up to 1 × 10
-2%, and the
induction was detectable already at 5 × 10
-4%. Alto-
gether, the results demonstrated that the inducible
expression system was functional and adjustable over a
large range of arabinose concentrations. The apparent
reduction in MuA expression at greater than 1 × 10
-2%
arabinose concentrations in this experiment is difficult
to explain, but it may conceivably relate to MuA overex-
pression possibly causing harmful effects on various cel-
lular functions and ultimately resulting in differences in
the growth rate.
Transposition frequency was subsequently analysed
under variable arabinose concentrations by the papilla-
tion assay (Figure 3b). Papillae began to appear at ~1 ×
10
-4% arabinose concentration, and the highest number
of discernible papillae was obtained at 1 × 10
-1%c o n -
centration. Higher arabinose concentrations apparently
affected cell survival significantly, as colonies were smal-
ler (Figure 3b) and ragged (data not shown). Further-
more, at these concentrations, the papillae were fuzzy
with diffuse colour and impossible to enumerate. These
data indicated that measurable papillation could be
induced over a wide range of arabinose concentrations.
In general, the MuA expression levels observed from
liquid cultures correlated well with the papillation data
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pancy was seen at 1 × 10
-1% arabinose concentration
(Figure 3a and 3b). This latter result likely reflects key
differences between the analyses, liquid versus plate cul-
tures. In liquid cultures, the ambient arabinose concen-
tration should be equal for all cells, and this is not
necessarily the case for cells growing as colonies on agar
plates. With regard to the arabinose concentration, the
microenvironment within a colony on a plate may vary
for each individual cell. Furthermore, the actual arabi-
nose concentration experienced by the cells within a
colony conceivably is, in general, somewhat lower than
that in the medium because of diffusion characteristics
and colony morphology.
The effect of MuA activity on transposition frequency
The suitability of the papillation assay for the quantita-
tive comparison of variable transposition frequencies
was examined using several MuA variants (Figure 4a).
We used an N-terminally deleted MuA77-663 as well as
C-terminally deleted variant MuA1-615, and in addition,
a variant missing both termini MuA77-615.W ea l s ou s e d
a MuA variant with a substitution in the catalytically
important active site DDE-triad (MuAE392Q), a protein
that is proficient for the transpososome assembly but
catalytically defective [36]. Standard papillation condi-
tions with 115-h incubation time were used in these
experiments.
The wild-type MuA and all of the deletion variants
studied produced papillae and responded to the increase
in the arabinose concentration (Figure 4b and Figure 5).
The wild-type protein produced ~300 papillae per col-
ony at the highest arabinose concentration tested (0.1%).
Both MuA1-615 and MuA77-615 produced significantly
less papillae with maximum yields of ~50 and ~200
papillae, respectively, indicating hypoactivity. MuA77-663
maximally gave rise to ~500 papillae and thus appeared
hyperactive. The active site mutant MuAE392Q did not
Table 1 Colony phenotypes and papillation characteristics in different E. coli strains
Strain Colony
size
a
Adjustabilitywith
arabinose
Maximum frequencyof
transposition
b
Distribution ofpapillae
on colonies
Papillae number dependency on the number of
growing colonies per plate
c
DH10B Large Limited High (up to ~100 papillae) Centered in the middle Somewhat dependent
DH5a Large Good Highest (up to ~300
papillae)
Even Largely independent
JM109 Medium Good Intermediate (up to ~40
papillae)
Even ND
d
HT321 Large Moderate Low (up to ~10 papillae) Even ND
aLarge colony size: up to ~5 mm of diameter. Medium colony size: up to ~3 mm of diameter.
bThe maximum frequency of transposition is specified in this table as the number of papillae per colony grown at 30°C for 115 h on a standard papillation
medium containing 0.1% arabinose.
cSee Additional file 2.
dND, not determined.
Figure 2 The effect of temperature on transposition frequency depending on temperature. The arabinose content in the growth medium
was 0.1%. The transposition frequency at 37°C is shown with an open triangle, at 30°C with a filled triangle, at 25°C with an open circle and at
room temperature (22°C) with a filled circle, respectively. Papillae were enumerated from six colonies for each data point. The error bars indicate
SD above and below the average value for each data point.
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reflecting its reported deficiency in catalysis. Similarly,
no papillae were generated when a pLHH4 derivative
(pTLH1), missing the MuA gene but retaining the Mu
ends, was assayed as a control (data not shown), high-
lighting the specificity of the system. These results indi-
cate that variable transposition activity levels can be
quantified reliably, demonstrating the suitability of the
papillation assay to screen transposase mutants with
altered activities. The data also show that the transposi-
tion frequency can be fine-tuned to a desired initial
level for screening purposes by the adjustment of the
arabinose concentration in the medium.
We include a time-lapsed video of growing colonies
from a papillation analysis (Additional file 3), which
highlights graphically the characteristics the developed
assay. The video was recorded using papillation condi-
tions where wild-type MuA produced only a few papil-
lae (1 × 10
-4% arabinose). Using these assay conditions,
we have recently identified a number of hyperactive
MuA variants, and a comprehensive analysis of critical
amino acid changes involved in their hyperactivity phe-
notype will be described in a future report.
Universal plasmid for papillation analysis
We next modified the papillation assay plasmid pLHH4
to be useful with other DNA transposons. In this modi-
fied plasmid, pSKT1 (Additional file 4), the Mu R-ends
have been replaced by polylinkers, allowing a straight-
forward directional cloning of heterologous transposon
ends. Similarly, the MuA transposase gene is also
replaced by a polylinker, facilitating directional cloning
Figure 3 The effect of growth conditions on transposition frequency. (a) Western blot analysis of MuA expression levels at varying
arabinose concentrations. Whole cell lysates from E. coli DH5a cells containing plasmid pLHH4 were analysed for MuA content using polyclonal
rabbit anti-MuA antibody. The asterisk indicates MuA. (b) The effect of arabinose concentration on colony size and papillation. Wild-type MuA-
expressing plasmid (pLHH4) was used for papillation analysis with E. coli DH5a as a plasmid recipient strain. Open and filled circles indicate the
colony size and the number of papillae per colony, respectively. Papillae were enumerated from six colonies for each data point. The error bars
indicate SD above and below the average value for each data point.
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the universal system was then confirmed as follows: (1)
Mu R-ends were recloned into the appropriate newly
made linker sites and tested in the context of wild-type
MuA; a similar number of papillae were generated, as
was observed with the original papillation assay plasmid
pLHH4 (data not shown). (2) When the Mu R-ends
were omitted, no papillae were produced, further illus-
trating the specificity of the assay system (similar to the
omission of the MuA transposase gene discussed above).
(3) Finally, the components of the IS903 transposition
system were introduced into pSKT1, and the ensuing
Figure 4 Papillation analysis of different MuA variants at varying arabinose concentrations. (a) MuA proteins used in papillation analysis.
Structural organisation of MuA with different functions assigned to various domains [14]. Amino acid numbers corresponding to the amino
terminus of each subdomain are shown beneath the structure. (b) In vivo transposition frequency induced by MuA variants. The transposition
frequency of MuA77-663 is shown with a filled circle, wild-type MuA with an open circle, MuA77-615 with a filled triangle, MuA1-615 with an open
triangle and MuAE392Q with a filled square, respectively. Papillae were enumerated from a total of three to six colonies for each data point. The
error bars indicate SD/2 above and below the average value for each data point.
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transpositional activity (results described in the next
subsection).
Analysis of IS903 transposition
Plasmid pSKT4, containing the critical components of
the IS903 transposition system, was introduced into
DH5a cells and analysed for papillation with variable
concentrations of arabinose in the growth medium. All
tested concentrations yielded papillae, and somewhat
surprisingly, even the plates which did not contain ara-
binose produced ~200 papillae per colony (data not
shown), indicating that IS903 transposase was expressed
at levels sufficient for transposition. We next tested
whether glucose, conceivably via catabolite repression,
could be used to tighten the control of transposase
Figure 5 Colonies from papillation assay. Papillation of MuA variants in DH5a at varying arabinose concentrations.
Pajunen et al. Mobile DNA 2010, 1:24
http://www.mobilednajournal.com/content/1/1/24
Page 8 of 14expression, which in turn would result in reduced levels
of papillation. A constant number of ~200 papillae were
produced with glucose concentrations up to 0.15% (data
not shown). However, higher concentrations of glucose
reduced the number of papillae essentially linearly, and
upon 0.25% concentration, no papillae were produced
(Figure 6). Thus, in cases where uninduced transposase
expression results in transposition frequency that is too
high for screening purposes, glucose can be used to
fine-tune papillae formation to a desirable level.
Discussion
Papillation assay systems have provided straightforward
means to dissect transposition events in vivo. For exam-
ple, they have enabled simultaneous activity analyses of
tens of thousands of randomly generated transposase
mutants [31,37-40]. Furthermore, such assays have suc-
cessfully been used to study the effects of mutations in
transposon end sequences [30,34,41-43] and to examine
the influence of host factors [33]. Although each parti-
cular assay system has performed adequately in the con-
text in which it has been used, in many cases
the adjustability has been limited. Furthermore, many of
the assays have included a reporter transposon and the
cognate transposase gene separately in different plas-
mids, which is not an ideal arrangement for many
applications.
The system we describe provides certain advantages.
First, the assay is based on an easy-to-use single plas-
mid, and it offers a straightforward means to visually
screen mutant versions of transposases as well as
potentiates the discovery of host factors affecting trans-
position. Second, the inclusion of two antibiotic marker
genes in the assay plasmid, bla and cat,e n a b l e sd o u b l e
antibiotic selection, which effectively prevents the
growth of satellite colonies on plates during the long
incubation period needed for papillation. Note that the
cat marker gene within the reporter transposon can also
be used for the selection of transposition events, a useful
feature in prospective downstream applications such as
mating-out assays. Third, the transposition frequency is
easily adjustable, which potentiates many types of stu-
dies under a desired optimal rate of transposition.
The expression system used in our assay, the arabi-
nose-controllable induction via PBAD promoter, has been
studied in detail previously [44]. The study revealed that
with standard E. coli strains harbouring native arabinose
transporter systems araE and araFGH, the arabinose-
inducible PBAD promoter is subject to essentially all-or-
none induction via a regulatory feedback loop, in which
limiting arabinose concentrations give rise to subpopula-
tions of cells that are either highly induced or unin-
duced [44]. Raising the arabinose concentration
increases the fraction of highly induced cells until a
saturating concentration is reached, under which con-
centration essentially all of the cells in the population
become highly induced [44]. Nevertheless, even under
these saturating arabinose concentrations, a degree of
variation exists among the expression levels of individual
cells [44]. Considering the above features, it was
expected that in our assay system, only a fraction of
cells would express the transposase within any given
colony under subsaturating arabinose concentrations,
and those cells expressing the transposase would be the
ones which ultimately produced the observed papillae.
Further considering the above features, although all-or-
none induction should generate two subpopulations of
cells, a degree of transposase expression variation should
Figure 6 Papillation analysis of IS903 transposition. Plasmid pSKT4 was introduced DH5a cells for papillation at varying glucose
concentrations. Papillae were enumerated from six colonies for each data point. The error bars indicate SD above and below the average value
for each data point.
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saturating and saturating arabinose concentrations.
Overall, our results have shown that good control of
population level average transposase expression can be
achieved using the PBAD promoter, at least under subsa-
turating arabinose concentrations. Under these condi-
tions, the transposase expression levels correlate very
well with the formation of papillae, forming a basis for a
dependable quantitative assay.
The omission of arabinose on selection plates effec-
tively eliminated transposition in the Mu system, but
identical conditions resulted in a reasonable level of
t r a n s p o s i t i o ni nt h eI S 903 system. These data indicate
that the PBAD control unit of transposase expression in
the papillation assay plasmid allows some basal protein
expression. As it is likely that similar expression levels
would be achieved independently of the expressed pro-
tein, the observed differences between Mu and IS903
most probably reflect differences in the inherent activ-
ities of the two systems (in the conditions tested) rather
than differences in the transposase expression levels.
The observed activity differences are necessarily not sur-
prising, because the analysed Mu system is somewhat
aberrant (unnatural transposon end configuration, lack
of transposition enhancer, lack of MuB protein),
whereas the analysed IS903 transpositionr e p r e s e n t sa
wild-type system.
We examined several E. coli strains for their suitability
in the papillation assay. From these studies, it became
evident that a number of critical attributes affecting the
assay performance were strain-dependent, evidently
reflecting known (plus possibly unknown) genotypic dif-
ferences, and by all criteria DH5a appeared optimal for
the assay. First, the large colony size and the even distri-
bution pattern of papillae within a colony allowed scor-
ing of more than 500 discernible papillae. Second, the
adjustability of the assay spans a wide range of arabinose
concentrations. Together, these attributes generated a
large dynamic range for the assay, and the use of glu-
cose extended the adjustability even further. Third, the
colony density on a plate did not influence papillation
appreciably, in practice meaning that reliable results
could be obtained from standard plates (diameter 9 cm)
containing ~50-200 growing colonies.
Several MuA variants were scrutinised for their trans-
positional activity to test the assay under different levels
of transposase activity. Overall, the results showed that
activities above and below a certain (in this case, wild-
type MuA) activity level could reliably be analysed,
potentiating the screen for hyperactive and hypoactive
mutants (Figure 4b and 5). MuA77-663, missing the Ia
domain [45], has been shown to be hyperactive in cer-
tain in vitro assays [46]. Similar hyperactivity was also
seen in its proficiency to produce papillae. MuA1-615,
lacking the C-terminal 48 amino acids [47], retains a
wild-type level of activity in certain in vitro assays
[47,48]. However, in our in vivo analysis, it was clearly
hypoactive. The details behind the apparent discrepancy
are unknown but may reflect the deficiency in the disas-
sembly of the transpososome via ClpX-mediated interac-
tion, a property confined to the C-terminus of MuA
[14]. MuA77-615,h a v i n gb o t ht h eI a domain and the C-
terminal residues deleted, retained substantial activity.
Thus, the hyperactivity-causing property of the domain
Ia deletion appeared to compensate for the activity
reduction caused by the deletion in the C-terminus.
Mu transposition can be reproduced in vitro using as
sole components MuA transposase, transposons that
contain 50 bp of Mu R-end in each transposon termi-
nus, and target DNA. This minimal reaction forms the
basis of the Mu in vitro transposition technology [15].
With an overall aim to improve the technology, we
designed our assay system to mimic this minimal in
vitro transposition reaction as closely as possible.
Accordingly, we used a reporter transposon which con-
tains two R-ends and did not include in the system the
known auxiliary factors of Mu transposition, such as the
transposition enhancer (IAS) and activator/targeting
protein MuB [14]. Our results demonstrate that Mu
transposition in vivo can proceed efficiently independent
of the natural L/R (left/right) end configuration and in
the absence of the above auxiliary factors. While a mas-
sive number of Mu studies have employed the natural
L/R end combination for studies in vivo, significantly
less in vivo data are available with regard the L/L or R/
R end configurations. Nevertheless, these configurations
have been shown to promote transposition in vivo, albeit
with reduced efficiency, and to generate correct junc-
tions between the Mu DNA and host DNA (unpub-
lished data in [49]). Falling outside the scope of the
current study, we did not analyse the effects on transpo-
sition of the known E. coli host factors, HU and IHF.
Nevertheless, it would be interesting to see whether
these two proteins were dispensable under the described
in vivo conditions as well.
The papillation assay platform should be applicable to
a number of transposition systems. For cut-and-paste
type transposons, papillation assays generate gene
fusions by the initial detachment of the transposon from
the donor site, followed by the integration of the trans-
poson into another locus. Thus, the mechanistic basis of
the assay for cut-and-paste transposons is relatively sim-
ple. However, Mu and IS903 primarily use the replica-
tive mode of transposition, a somewhat more
complicated mechanism. During replicative transposi-
tion, a branched transposition intermediate (a/k/a Sha-
piro intermediate) is formed. This intermediate can be
processed either by DNA replication or by DNA repair,
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processing [50]. However, in this work, we have not stu-
died the mechanistic details of the assay. Recent findings
indicate that several pathways may be involved in the
processing of the Shapiro intermediate [50], which
necessarily would complicate such studies. As retro-
viruses and LTR retrotransposons catalyse a mechanisti-
cally related (transposition) reaction called integration
[1], it might be possible to apply the assay platform also
for them. However, in these cases, the interplay between
the integrase protein and other proteins of the integra-
tion machinery may complicate the development of a
useable strategy.
Conclusions
We have established a papillation assay platform which
is easily modifiable for a variety of transposon systems.
It provides an efficient tool for the studies of yet
unknown transposons and yields means to screen and
scrutinise transposase mutants as well as genes encoding
critical host factors involved in transposition. Although
in this paper we used the papillation assay with two pro-
karyotic transposons, the system may equally be applied
to eukaryotic DNA transposons as well. It is hoped that
the use of the developed platform will generate better
versions of transposition systems, ultimately producing
better tools for molecular biology and offering versatile
genome modification vehicles for a variety of future stu-
dies. These investigations are expected to involve disci-
plines such as cancer biology, gene therapy, stem cell
research and studies on transgenesis.
Methods
Bacteria, plasmids and oligonucleotides
Escherichia coli strains are listed in Additional file 1.
Plasmids and oligonucleotides are described in Addi-
tional file 6 and Additional file 7, respectively.
Reagents, enzymes and DNA techniques
Ampicillin, chloramphenicol, arabinose and glucose
were from Sigma (St. Louis, MO, USA). Lactose was
from BDH/VWR International (West Chester, PA, USA)
and 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside
(X-gal) was from AppliChem GmbH (Darmstadt, Ger-
many). Restriction endonucleases and T4 DNA ligase
were from New England BioLabs (Ipswich, MA, USA).
Calf intestinal phosphatase (CIP) was from Finnzymes
(Espoo, Finland). Standard DNA techniques were per-
formed as described previously [51]. Plasmids were pro-
pagated in E. coli DH5a and were isolated using
appropriate Qiagen (Hilden, Germany) kits. Electrocom-
petent DH5a cells were prepared as described pre-
viously [24] and used for standard cloning procedures.
Construction of the papillation assay plasmid expressing
wild-type MuA transposase
The papillation assay plasmid pLHH4 (Figure 1a),
expressing wild-type MuA transposase (GenBank acces-
sion number P07636) was generated as follows: (1) A
truncated version of the lacZ gene, encoding E. coli
b-galactosidase (EC 3.2.1.23) but missing the nucleotides
specifying the amino acids 1-8 (Δ1-8lacZ), was amplified
by polymerase chain reaction (PCR) from plasmid
pNT105 using the primer pair HSP173/HSP408. The
generated PCR fragment was trimmed with BamHI and
subsequently cloned into plasmid pSupF-Mu between
the two BamHI sites to replace the supF gene, yielding
plasmid pLHH1. (2) The cat gene was amplified by PCR
from plasmid pBC SK(+) using the primer pair HSP360/
HSP361. The generated PCR fragment was trimmed
with BamHI and cloned downstream of Δ1-8lacZ into
BamHI-linearized pLHH1 (partial digestion), yielding
plasmid pLHH2. Prior to cloning, the cat gene was
modified by introducing, via overlap PCR with appropri-
ate primers, a silent mutation (codon 177, Thr,
ACC®ACT) to eliminate a critical NcoIs i t e .( 3 )A n
SphI-fragment containing the tandem E. coli rrnB termi-
nators T1+T2 [52] and phage l tR’ terminator [53] as
well as a critical BamHI site for cloning was generated
by standard DNA techniques including PCR and anneal-
ing of oligonucleotides (see Additional file 7). (4) The
above terminator-containing SphI-fragment was then
cloned into SphI-digested pALH6 to generate pLHH3.
(5) Finally, the mini-Mu transposon of pLHH2 was
released with BglI Ia n dc l o n e di n t oBamHI-linearised
pLHH3 (partial digestion) to generate pLHH4.
MuA variant-expressing papillation assay plasmids
Initially, plasmid pTLH1 was generated by cloning the
5.2-kb SphI reporter-containing fragment of pLHH4
into SphI-digested pBADHisA, which substituted the
MuA gene with the polylinker of pBADHisA. PCR-gen-
erated MuA deletion variants (pMPH14, pMPH17,
pMPH18; see Additional fil e s6a n d7 )w e r es u b s e -
quently cloned between the NcoIa n dXhoIs i t e so f
pTLH1. The plasmid expressing MuAE392Q (pLHH12)
was generated by cloning the NcoI-BamHI fragment of
pMK616 into pTLH1 digested with NcoI and BglII.
Construction of universal papillation assay plasmid
Initially, the reporter region of pLHH2 containing the
Δ1-8lacZ and cat genes was amplified by PCR using the
linker-sequence-tailed primers HSP685 and HSP689 (see
Additional file 7). The generated PCR fragment was
trimmed with BglII and cloned into BamHI-linearized
pLHH3 (partial digestion), yielding plasmid pMPH23B.
Finally, the universal papillation assay plasmid pSKT1
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containing NcoI-ScaI fragment of pMPH23B with the
polylinker-containing NcoI-ScaI fragment of pBADHisA.
Plasmid pSKT1 can be applied to establish a papillation
assay for various transposon systems in three straight-
forward cloning steps involving transposon ends and a
cognate transposase gene.
Construction of papillation assay plasmid for IS903
The IS903 transposase gene was amplified by PCR from
plasmid pNT105 using the primer pair HSP693/HSP694.
The PCR fragment was trimmed with NcoIa n dXhoI
and cloned into plasmid pSKT1 digested with the same
two enzymes, yielding plasmid pSKT2. The ends of
IS903 were then inserted as follows. First, oligonucleo-
tides HSP690 and HSP691 were annealed and cloned
into pSKT2 digested with SpeIa n dNotI, resulting in
plasmid pSKT3. Second, oligonucleotides HSP690 and
HSP692 were annealed and cloned into pSKT3, digested
initially with XbaI and then partially with XmaI, yielding
the IS903 papillation assay plasmid pSKT4.
Papillation assay
Each papillation assay plasmid was transformed into
competent E. coli cells prepared and used as described
previously [54]. In a standard assay, cells were plated at
approximately 100 c.f.u. (colony forming units) per
plate. Standard plates contained LB medium [51] sup-
plemented with 1.5% Bacto-agar (Difco/Becton Dickin-
son and Company, Sparks, MD, USA), 100 μg/ml
ampicillin (Ap), 20 μg/ml chloramphenicol (Cm), 0.05%
lactose, 40 μg/ml X-gal, and 0.1% arabinose. For the
experiments with IS903 transposition, glucose replaced
arabinose for the adjustment of the transposase expres-
sion. In standard assays, the plates were incubated at 30°
C for 115 h. To study the suitability of different E. coli
strains, the effect of arabinose concentration, as well as
growth temperature and time, were varied. The effect
on papillation of the number of growing colonies per
plate was studied by plating cells to produce different
colony densities. For each data point, three to six repre-
sentative colonies were photographed using an Olympus
(Tokyo, Japan) ColorView II digital camera attached to
an Olympus SZX12 stereomicroscope equipped with
Zeiss (Oberkochen, Germany) KL1500 LCD cold light
source. The size of the colonies was measured, and the
number of papillae in each colony was enumerated
manually by the use of AnalySIS software (Soft Imaging
System, Olympus). The same imaging system was used
for the time-lapsed video recording (Additional file 3).
Western blotting
T h ee x p r e s s i o no fw i l d - t y p eM u Ap r o t e i na td i f f e r e n t
arabinose concentrations was determined by analysing
whole-cell lysates using sodium dodecyl sulphate-polya-
crylamide gel electrophoresis (SDS-PAGE). For protein
expression, E. coli DH5a(pLHH4) cells were grown in
LB-Ap-Cm medium (5 ml) at 37°C to an OD600 of 0.5,
and MuA expression was induced by the addition of
arabinose. Following incubation at 28°C for 2 h, cells
from 0.5 ml of the culture were pelleted and resus-
pended in 150 μl of 1× SB loading buffer (100 mM
Tris·HCl, pH 6.8, 200 mM dithiothreitol, 4% SDS, 0.2%
bromophenol blue, 20% wt/wt glycerol). The proteins (5
μl of 1:8 diluted sample in 1× SB) were separated on a
10% SDS-PAGE gel and blotted onto Immobilon™P
polyvinylidene difluoride membrane (Millipore, Billerica,
MD, USA) using the Mini Trans-Blot Electrophoretic
Transfer Cell (Bio-Rad, Hercules, CA, USA), according
to the manufacturer’s instructions. The membrane was
blocked at room temperature overnight using 5% skim
milk powder dissolved in phosphate-buffered saline
(PBS) buffer [51]. Following a wash with PBS, the mem-
brane was probed with the primary rabbit anti-MuA
antibody (1:1,000 dilution) and subsequently with the
secondary horseradish peroxidase-conjugated anti-rabbit
(from donkey; Amersham Biosciences/GE Healthcare,
Buckinghamshire, United Kingdom) Ig antibody
(1:10,000 dilution). The bound peroxidase was detected
using the ECL Plus Western Blotting System (Amer-
sham Biosciences/GE Healthcare,) as specified by the
supplier. Immunoreactive bands were visualized using a
Fujifilm LAS-3000 system (Fujifilm Corporation, Tokyo,
Japan).
Additional material
Additional file 1: Supp. Table 1. E. coli strains. E. coli strains used in
the work.
Additional file 2: Supp. Fig. 1. Dependency of papillae number per
colony on the number of growing colonies. Bacterial colonies were
grown at different densities (upper left corner) on a standard 9-cm plate.
Colony size and the corresponding number of papillae were determined.
(a) Strain DH10B. (b) Strain DH5a.
Additional file 3: Supp. Video 1. Time-lapsed video of papillation
assay. Shown are bacterial colonies growing on a standard papillation
medium containing 1 × 10
-4 % arabinose. The standard X-gal
concentration was increased to 120 μg/ml to enhance contrast. The
plates were incubated initially at 25°C for 46.5 h in an unilluminated
chamber. Subsequently, for recording, the plates were transferred under
a microscope with an artificial LCD light source. The recording was done
at ~22°C with 1-h time lapse intervals for 6 days (144 h). The colonies
shown represent wild-type MuA (Wild type) and MuA63-663 (Del-N).
Additional file 4: Supp. Fig. 2. Universal papillation assay plasmid
pSKT1. This plasmid is identical to pLHH4 (see Figure 1a), except that
the MuA transposase gene and Mu R-ends are replaced by polylinkers
(NcoI 319-HindIII 467, SpeI 3560-NotI 3567, XmaI 7777-XbaI 7789,
respectively). Unique restriction sites are shown in red font.
Additional file 5: Supp. Fig. 3. Papillation assay plasmid pSKT4 for
IS903 transposition. This plasmid contains the IS903 transposase gene
and the transposon ends within the polylinkers of pSKT1 (see Additional
file 4).
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Page 12 of 14Additional file 6: Supp. Table 2. Plasmids. Plasmids used in the work.
Additional file 7: Supp. Table 3. Oligonucleotides. Oligonucleotides
used in the work.
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